Country: Unjoni Ewropea
Lingwa: Ingliż
Sors: EMA (European Medicines Agency)
difloxacin
Pfizer Limited
QJ01MA94
difloxacin
Turkeys; Dogs; Cattle; Chicken
Antibacterials for systemic use, Antiinfectives for systemic use
Chickens:for the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.Turkeys:For the treatment of chronic respiratory infections caused by sensitive strains of Escherichia coli and Mycoplasma gallisepticum.Also for the treatment of infections caused by Pasteurella multocida.Dogs:For the treatment of acute uncomplicated urinary-tract infections caused by Escherichia coli or Staphylococcus spp. and superficial pyoderma caused by Staphylococcus intermedius.Cattle:For the treatment of bovine respiratory disease (shipping fever, calf pneumonia) caused by single or mixed infections with Pasteurella haemolytica, Pasteurella multocida and / or Mycoplasma spp.
Revision: 7
Withdrawn
1998-01-16
Medicinal product no longer authorised 42 B. PACKAGE LEAFLET Medicinal product no longer authorised 43 PACKAGE LEAFLET FOR DICURAL 100 MG/ML ORAL SOLUTION FOR CHICKENS AND TURKEYS 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE MARKETING AUTHORISATION HOLDER Pfizer Limited Ramsgate Road Sandwich Kent CT13 9NJ United Kingdom MANUFACTURER FOR THE BATCH RELEASE Pfizer Olot, S.L.U. Ctra. Camprodón, s/n°, Finca La Riba, Vall de Bianya, 17813 Girona Spain 2. NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 100 mg/ml oral solution for chickens and turkeys 3. STATEMENT OF THE ACTIVE SUBSTANCE AND OTHER INGREDIENT(S) Each ml contains: ACTIVE SUBSTANCE Difloxacin (as hydrochloride) 100 mg EXCIPIENTS Other excipients, including benzyl alcohol, in an aqueous formulation to 1 ml 4. INDICATIONS In chickens and turkeys: Dicural oral solution is indicated for treatment of chronic respiratory infections caused by sensitive strains of _Escherichia coli_ and _Mycoplasma gallisepticum_ . In turkeys: Dicural oral solution is also indicated for the treatment of infections caused by _Pasteurella _ _multocida._ Dicural oral solution should only be used based on susceptibility testing 5. CONTRAINDICATIONS Since no studies were performed in clinically lame birds, Dicural oral solution should not be used in birds with existing leg-weakness or in birds suffering from osteoporosis. Medicinal product no longer authorised 44 6. ADVERSE REACTIONS If you notice any serious effects or other effects not mentioned in this leaflet, please inform your veterinary surgeon. 7. TARGET SPECIES Chickens (broilers and future breeders) Turkeys (young turkeys up to 2 kg body weight). 8. DOSAGE FOR EACH SPECIES, METHOD AND ROUTE OF ADMINISTRATION Dicural oral solution must be administrated daily via the drinking water in such a concentration that the dose is 10 mg/kg bodyweight. The administration must be continued for 5 days. For oral administration in drinking water. Taki Aqra d-dokument sħiħ
Medicinal product no longer authorised 1 ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS Medicinal product no longer authorised 2 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Dicural 100 mg/ml oral solution for chickens and turkeys 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Difloxacin (as hydrochloride) 100 mg EXCIPIENTS: Benzyl alcohol 100 mg For a full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral solution 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chickens (broilers and future breeders) Turkeys (young turkeys up to 2 kg body weight). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES In chickens and turkeys: Dicural oral solution is indicated for treatment of chronic respiratory infections caused by sensitive strains of _Escherichia coli_ and _Mycoplasma gallisepticum_ . In turkeys : Dicural oral solution is also indicated for the treatment of infections caused by _Pasteurella _ _multocida_ . 4.3 CONTRAINDICATIONS Since no studies were performed in clinically lame birds, Dicural should not be used in birds with existing leg-weakness or in birds suffering from osteoporosis. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS Heavy reliance on a single class of antibiotics may result in the induction of resistance in a bacterial population. It is prudent to reserve the fluoroquinolones for the treatment of clinical conditions that have responded poorly, or are expected to respond poorly, to other classes of antibiotics. Official and local antimicrobial policies should be taken into account when the product is used . Whenever possible, fluoroquinolones should only be used based on susceptibility testing. Medicinal product no longer authorised 3 Use of the product deviating from the instructions given in the SPC may increase the prevalence of bacteria resistant to the fluoroquinolones and may decrease the effectiveness of treatment with other quinolones due to the potential of cross resistance Aqra d-dokument sħiħ